Dopamine oxidation Merchandise as Mitochondrial Endotoxins, a Potential Molecular Mechanism for Preferential Neurodegeneration in Parkinson’s Sickness.
The preferential degeneration of dopaminergic neurons inside the substantia nigra pars compacta is accountable for the motor impairment associated to Parkinson’s sickness. Dopamine is a extraordinarily reactive molecule, which is often saved inside synaptic vesicles the place it is stabilized by the ambient low pH.
Nonetheless, free cytosolic dopamine can auto-oxidize, producing reactive oxygen species, and end result within the formation of toxic quinones. Throughout the present work, we’ve got now analyzed the mechanisms by the use of which the dysfunction of dopamine homeostasis might induce cell toxicity, by focusing particularly on the hurt induced by dopamine oxidation merchandise on the mitochondrial diploma.
Our outcomes level out that dopamine derivatives impact mitochondrial morphology and induce mitochondrial membrane depolarization, leading to a reduction of ATP synthesis. Moreover, our outcomes counsel that opening of the mitochondrial transition pore induced by dopamine-derived quinones may contribute to the exact Parkinson’s disease-associated vulnerability of dopamine containing neurons.
Mouse antibody for Epstein-Barr virus EA-D |
|||
| 261 | Virostat | 100 ug | EUR 386.26 |
|
Description: This is purified Mouse monoclonal antibody against Epstein-Barr virus EA-D for WB, ELISA. |
|||
NATtrol Epstein Barr Virus (EBV) Strain:B95-8,External Run Control-Medium(6X1mL) |
|||
| NATEBV-ERCM | Zeptometrix | 6X1mL | EUR 469.34 |
|
Description: Please contact Gentaur in order to receive the datasheet of the product. |
|||
Epstein-Barr virus Epstein-Barr nuclear antigen 2 (EBNA2) |
|||
| 1-CSB-YP718162EEZ(A4) | Cusabio |
|
|
|
Description: Recombinant Epstein-Barr virus Epstein-Barr nuclear antigen 2(EBNA2),partial expressed in Yeast |
|||
Epstein-Barr virus Epstein-Barr nuclear antigen 3 (EBNA3) |
|||
| 1-CSB-EP319032EFA | Cusabio |
|
|
|
Description: Recombinant Epstein-Barr virus Epstein-Barr nuclear antigen 3 (EBNA3),partial expressed in E.coli |
|||
Epstein-Barr virus Epstein-Barr nuclear antigen 1 (EBNA1) |
|||
| 1-CSB-EP365878EFA | Cusabio |
|
|
|
Description: Recombinant Epstein-Barr virus Epstein-Barr nuclear antigen 1(EBNA1),partial expressed in E.coli |
|||
Mouse antibody for Epstein-Barr virus gp 250/350 |
|||
| 221 | Virostat | 100 ug | EUR 386.26 |
|
Description: This is purified Mouse monoclonal antibody against Epstein-Barr virus gp 250/350 for WB, ELISA. |
|||
Mouse antibody for Epstein-Barr virus Bam H1 Z |
|||
| 256 | Virostat | 100 ug | EUR 386.26 |
|
Description: This is purified Mouse monoclonal antibody against Epstein-Barr virus Bam H1 Z for WB, ELISA. |
|||
Epstein-Barr Virus (EBV) Antibody |
|||
| abx021696-1mg | Abbexa | 1 mg | EUR 1387.2 |
Epstein-Barr Virus (EBV) Antibody |
|||
| abx021699-1mg | Abbexa | 1 mg | EUR 1387.2 |
Epstein-Barr Virus (EBV) Antibody |
|||
| abx021702-1mg | Abbexa | 1 mg | EUR 1387.2 |
Epstein-Barr Virus Nuclear Antigen |
|||
| abx670096-01mg | Abbexa | 0.1 mg | EUR 1429.2 |
Anti-Epstein Barr Virus antibody |
|||
| STJ16100364 | St John's Laboratory | 1 mL | EUR 904.8 |
EBV Antibody / Epstein-Barr Virus |
|||
| V8302-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: Clone CS1 is one of four clones to EBV. Each clone reacts with different epitopes on the hydrophilic C-terminus of the cytoplasmic domain of LMP-1. This antibody is specific to 60kDa latent membrane protein (LMP-1) encoded by the BNLF1 gene of the EBV. It stains strongly with EBV-positive lymphoblastoid cell lines and EBV infected B cell immunoblasts in infectious mononucleosis. EBV, also designated human herpesvirus 4 (HHV-4), is a member of the herpesvirus family and is one of the most common human viruses. EBV infects B cells and, though often asymptomatic, it can cause infectious mononucleosis, a disease characterized by fatigue, fever, sore throat and muscle soreness. |
|||
EBV Antibody / Epstein-Barr Virus |
|||
| V8302-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
|
Description: Clone CS1 is one of four clones to EBV. Each clone reacts with different epitopes on the hydrophilic C-terminus of the cytoplasmic domain of LMP-1. This antibody is specific to 60kDa latent membrane protein (LMP-1) encoded by the BNLF1 gene of the EBV. It stains strongly with EBV-positive lymphoblastoid cell lines and EBV infected B cell immunoblasts in infectious mononucleosis. EBV, also designated human herpesvirus 4 (HHV-4), is a member of the herpesvirus family and is one of the most common human viruses. EBV infects B cells and, though often asymptomatic, it can cause infectious mononucleosis, a disease characterized by fatigue, fever, sore throat and muscle soreness. |
|||
EBV Antibody / Epstein-Barr Virus |
|||
| V8302SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: Clone CS1 is one of four clones to EBV. Each clone reacts with different epitopes on the hydrophilic C-terminus of the cytoplasmic domain of LMP-1. This antibody is specific to 60kDa latent membrane protein (LMP-1) encoded by the BNLF1 gene of the EBV. It stains strongly with EBV-positive lymphoblastoid cell lines and EBV infected B cell immunoblasts in infectious mononucleosis. EBV, also designated human herpesvirus 4 (HHV-4), is a member of the herpesvirus family and is one of the most common human viruses. EBV infects B cells and, though often asymptomatic, it can cause infectious mononucleosis, a disease characterized by fatigue, fever, sore throat and muscle soreness. |
|||
EBV Antibody / Epstein-Barr Virus |
|||
| V8316-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: Clone CS2 is one of four clones to EBV. Each clone reacts with different epitopes on the hydrophilic C-terminus of the cytoplasmic domain of LMP-1. This antibody is specific to 60kDa latent membrane protein (LMP-1) encoded by the BNLF1 gene of the EBV. It stains strongly with EBV-positive lymphoblastoid cell lines and EBV infected B cell immunoblasts in infectious mononucleosis. EBV, also designated human herpesvirus 4 (HHV-4), is a member of the herpesvirus family and is one of the most common human viruses. EBV infects B cells and, though often asymptomatic, it can cause infectious mononucleosis, a disease characterized by fatigue, fever, sore throat and muscle soreness. |
|||
EBV Antibody / Epstein-Barr Virus |
|||
| V8316-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
|
Description: Clone CS2 is one of four clones to EBV. Each clone reacts with different epitopes on the hydrophilic C-terminus of the cytoplasmic domain of LMP-1. This antibody is specific to 60kDa latent membrane protein (LMP-1) encoded by the BNLF1 gene of the EBV. It stains strongly with EBV-positive lymphoblastoid cell lines and EBV infected B cell immunoblasts in infectious mononucleosis. EBV, also designated human herpesvirus 4 (HHV-4), is a member of the herpesvirus family and is one of the most common human viruses. EBV infects B cells and, though often asymptomatic, it can cause infectious mononucleosis, a disease characterized by fatigue, fever, sore throat and muscle soreness. |
|||
EBV Antibody / Epstein-Barr Virus |
|||
| V8316SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: Clone CS2 is one of four clones to EBV. Each clone reacts with different epitopes on the hydrophilic C-terminus of the cytoplasmic domain of LMP-1. This antibody is specific to 60kDa latent membrane protein (LMP-1) encoded by the BNLF1 gene of the EBV. It stains strongly with EBV-positive lymphoblastoid cell lines and EBV infected B cell immunoblasts in infectious mononucleosis. EBV, also designated human herpesvirus 4 (HHV-4), is a member of the herpesvirus family and is one of the most common human viruses. EBV infects B cells and, though often asymptomatic, it can cause infectious mononucleosis, a disease characterized by fatigue, fever, sore throat and muscle soreness. |
|||
EBV Antibody / Epstein-Barr Virus |
|||
| V8326-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: Clone CS3 is one of four clones to EBV. Each clone reacts with different epitopes on the hydrophilic C-terminus of the cytoplasmic domain of LMP-1. This antibody is specific to 60kDa latent membrane protein (LMP-1) encoded by the BNLF1 gene of the EBV. It stains strongly with EBV-positive lymphoblastoid cell lines and EBV infected B cell immunoblasts in infectious mononucleosis. EBV, also designated human herpesvirus 4 (HHV-4), is a member of the herpesvirus family and is one of the most common human viruses. EBV infects B cells and, though often asymptomatic, it can cause infectious mononucleosis, a disease characterized by fatigue, fever, sore throat and muscle soreness. |
|||
EBV Antibody / Epstein-Barr Virus |
|||
| V8326-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
|
Description: Clone CS3 is one of four clones to EBV. Each clone reacts with different epitopes on the hydrophilic C-terminus of the cytoplasmic domain of LMP-1. This antibody is specific to 60kDa latent membrane protein (LMP-1) encoded by the BNLF1 gene of the EBV. It stains strongly with EBV-positive lymphoblastoid cell lines and EBV infected B cell immunoblasts in infectious mononucleosis. EBV, also designated human herpesvirus 4 (HHV-4), is a member of the herpesvirus family and is one of the most common human viruses. EBV infects B cells and, though often asymptomatic, it can cause infectious mononucleosis, a disease characterized by fatigue, fever, sore throat and muscle soreness. |
|||
EBV Antibody / Epstein-Barr Virus |
|||
| V8326SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: Clone CS3 is one of four clones to EBV. Each clone reacts with different epitopes on the hydrophilic C-terminus of the cytoplasmic domain of LMP-1. This antibody is specific to 60kDa latent membrane protein (LMP-1) encoded by the BNLF1 gene of the EBV. It stains strongly with EBV-positive lymphoblastoid cell lines and EBV infected B cell immunoblasts in infectious mononucleosis. EBV, also designated human herpesvirus 4 (HHV-4), is a member of the herpesvirus family and is one of the most common human viruses. EBV infects B cells and, though often asymptomatic, it can cause infectious mononucleosis, a disease characterized by fatigue, fever, sore throat and muscle soreness. |
|||
EBV Antibody / Epstein-Barr Virus |
|||
| V8330-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: Clone CS4 is one of four clones to EBV. Each clone reacts with different epitopes on the hydrophilic C-terminus of the cytoplasmic domain of LMP-1. This antibody is specific to 60kDa latent membrane protein (LMP-1) encoded by the BNLF1 gene of the EBV. It stains strongly with EBV-positive lymphoblastoid cell lines and EBV infected B cell immunoblasts in infectious mononucleosis. EBV, also designated human herpesvirus 4 (HHV-4), is a member of the herpesvirus family and is one of the most common human viruses. EBV infects B cells and, though often asymptomatic, it can cause infectious mononucleosis, a disease characterized by fatigue, fever, sore throat and muscle soreness. |
|||
EBV Antibody / Epstein-Barr Virus |
|||
| V8330-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
|
Description: Clone CS4 is one of four clones to EBV. Each clone reacts with different epitopes on the hydrophilic C-terminus of the cytoplasmic domain of LMP-1. This antibody is specific to 60kDa latent membrane protein (LMP-1) encoded by the BNLF1 gene of the EBV. It stains strongly with EBV-positive lymphoblastoid cell lines and EBV infected B cell immunoblasts in infectious mononucleosis. EBV, also designated human herpesvirus 4 (HHV-4), is a member of the herpesvirus family and is one of the most common human viruses. EBV infects B cells and, though often asymptomatic, it can cause infectious mononucleosis, a disease characterized by fatigue, fever, sore throat and muscle soreness. |
|||
EBV Antibody / Epstein-Barr Virus |
|||
| V8330SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: Clone CS4 is one of four clones to EBV. Each clone reacts with different epitopes on the hydrophilic C-terminus of the cytoplasmic domain of LMP-1. This antibody is specific to 60kDa latent membrane protein (LMP-1) encoded by the BNLF1 gene of the EBV. It stains strongly with EBV-positive lymphoblastoid cell lines and EBV infected B cell immunoblasts in infectious mononucleosis. EBV, also designated human herpesvirus 4 (HHV-4), is a member of the herpesvirus family and is one of the most common human viruses. EBV infects B cells and, though often asymptomatic, it can cause infectious mononucleosis, a disease characterized by fatigue, fever, sore throat and muscle soreness. |
|||
EBV Antibody / Epstein-Barr Virus |
|||
| V8335-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: This antibody cocktail is a mixture of four different monoclonal antibodies (CS1 + CS2 + CS3 + CS4). It is specific to 60kDa latent membrane protein (LMP-1) encoded by the BNLF1 gene of the EBV. Each clone reacts with different epitopes on the hydrophilic C-terminus of the cytoplasmic domain of LMP-1. The cocktail stains strongly with EBV-positive lymphoblastoid cell lines and EBV infected B cell immunoblasts in infectious mononucleosis. EBV, also designated human herpesvirus 4 (HHV-4), is a member of the herpesvirus family and is one of the most common human viruses. EBV infects B cells and, though often asymptomatic, it can cause infectious mononucleosis, a disease characterized by fatigue, fever, sore throat and muscle soreness. |
|||
EBV Antibody / Epstein-Barr Virus |
|||
| V8335-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
|
Description: This antibody cocktail is a mixture of four different monoclonal antibodies (CS1 + CS2 + CS3 + CS4). It is specific to 60kDa latent membrane protein (LMP-1) encoded by the BNLF1 gene of the EBV. Each clone reacts with different epitopes on the hydrophilic C-terminus of the cytoplasmic domain of LMP-1. The cocktail stains strongly with EBV-positive lymphoblastoid cell lines and EBV infected B cell immunoblasts in infectious mononucleosis. EBV, also designated human herpesvirus 4 (HHV-4), is a member of the herpesvirus family and is one of the most common human viruses. EBV infects B cells and, though often asymptomatic, it can cause infectious mononucleosis, a disease characterized by fatigue, fever, sore throat and muscle soreness. |
|||
EBV Antibody / Epstein-Barr Virus |
|||
| V8335SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: This antibody cocktail is a mixture of four different monoclonal antibodies (CS1 + CS2 + CS3 + CS4). It is specific to 60kDa latent membrane protein (LMP-1) encoded by the BNLF1 gene of the EBV. Each clone reacts with different epitopes on the hydrophilic C-terminus of the cytoplasmic domain of LMP-1. The cocktail stains strongly with EBV-positive lymphoblastoid cell lines and EBV infected B cell immunoblasts in infectious mononucleosis. EBV, also designated human herpesvirus 4 (HHV-4), is a member of the herpesvirus family and is one of the most common human viruses. EBV infects B cells and, though often asymptomatic, it can cause infectious mononucleosis, a disease characterized by fatigue, fever, sore throat and muscle soreness. |
|||
NATtrol Epstein Barr Virus (EBV) Strain: B95-8, External Run Control-Low (6X1mL) |
|||
| NATEBV-ERCL | Zeptometrix | 6X1mL | EUR 395.71 |
|
Description: Please contact Gentaur in order to receive the datasheet of the product. |
|||
ELISA kit for Human epstein-barr virus (EBv)antibody (IgG) |
|||
| EK0203 | SAB | 96 tests | EUR 996 |
|
Description: Enzyme-linked immunosorbent assay kit for quantification of Human epstein-barr virus (EBv)antibody (IgG) in samples from serum, plasma, tissue homogenates and other biological fluids. |
|||
ELISA kit for Human epstein-barr virus (Ebv) antibody (IgM) |
|||
| EK0204 | SAB | 96 tests | EUR 996 |
|
Description: Enzyme-linked immunosorbent assay kit for quantification of Human epstein-barr virus (Ebv) antibody (IgM) in samples from serum, plasma, tissue homogenates and other biological fluids. |
|||
Epstein-Barr virus Glycoprotein BDLF3 (BDLF3) |
|||
| 1-CSB-EP365881EFA1 | Cusabio |
|
|
|
Description: Recombinant Epstein-Barr virus Glycoprotein BDLF3(BDLF3),partial expressed in E.coli |
|||
Epstein-Barr Virus (EBV) Antibody (FITC) |
|||
| abx021698-100ug | Abbexa | 100 ug | EUR 878.4 |
Anti-Human Epstein-Barr Virus antibody |
|||
| STJ16100457 | St John's Laboratory | 1 mL | EUR 288 |
Anti-Epstein-Barr virus LMP antibody |
|||
| STJ16100853 | St John's Laboratory | 1 mL | EUR 1156.8 |
ELISA kit for Mouse EBI3 (Epstein Barr Virus Induced Protein 3) |
|||
| ELK6316 | ELK Biotech | 1 plate of 96 wells | EUR 518.4 |
|
Description: A sandwich ELISA kit for detection of Epstein Barr Virus Induced Protein 3 from Mouse in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
|||
Purified Nipah virus Glycoprotein control for Western Blotting |
|||
| NIV11-C | Alpha Diagnostics | 100 ul | EUR 343.2 |
Purified Nipah virus Nucleoprotein control for Western Blotting |
|||
| NIV21-C | Alpha Diagnostics | 100 ul | EUR 270 |
Recombinant Epstein–Barr Virus P23, GST-tagged |
|||
| DAG511 | Creative Diagnostics | 1mg | EUR 1334.4 |
Epstein Barr Virus NA1 IgA ELISA Kit |
|||
| DEIA1030 | Creative Diagnostics | 96T | EUR 667.2 |
|
Description: For the qualitative determination of IgA class antibodies against Epstein Barr Virus in Human serum or plasma. It is intended for diagnosing and monitoring of patients related to infection by Epstein Barr Virus. |
|||
Epstein Barr Virus Zta IgA ELISA Kit |
|||
| DEIA1034 | Creative Diagnostics | 96T | EUR 667.2 |
|
Description: For the qualitative determination of IgA class antibodies against Epstein Barr Virus in Human serum or plasma. It is intended for diagnosing and monitoring of patients related to infection by Epstein Barr Virus. |
|||
Epstein-Barr virus Apoptosis regulator BHRF1 (BHRF1) |
|||
| 1-CSB-EP314488EFC | Cusabio |
|
|
|
Description: Recombinant Epstein-Barr virus Apoptosis regulator BHRF1(BHRF1),partial expressed in E.coli |
|||
Epstein-Barr virus Envelope glycoprotein B (gB) |
|||
| 1-CSB-EP355975EFA | Cusabio |
|
|
|
Description: Recombinant Epstein-Barr virus Envelope glycoprotein B(gB),partial expressed in E.coli |
|||
Epstein-Barr virus Envelope glycoprotein L (gL) |
|||
| 1-CSB-EP355982EFA | Cusabio |
|
|
|
Description: Recombinant Epstein-Barr virus Envelope glycoprotein L(gL) expressed in E.coli |
|||
Epstein-Barr virus Envelope glycoprotein GP350 (BLLF1) |
|||
| 1-CSB-EP360986EFA | Cusabio |
|
|
|
Description: Recombinant Epstein-Barr virus Envelope glycoprotein GP350(BLLF1),partial expressed in E.coli |
|||
Epstein-Barr virus Envelope glycoprotein H (gH) |
|||
| 1-CSB-EP365883EFA | Cusabio |
|
|
|
Description: Recombinant Epstein-Barr virus Envelope glycoprotein H(gH),partial expressed in E.coli |
|||
Recombinant Human Epstein Barr Virus Induced 3 |
|||
| 7-00256 | CHI Scientific | 2µg | Ask for price |
Recombinant Human Epstein Barr Virus Induced 3 |
|||
| 7-00257 | CHI Scientific | 10µg | Ask for price |
Recombinant Human Epstein Barr Virus Induced 3 |
|||
| 7-00258 | CHI Scientific | 1mg | Ask for price |
Recombinant Mouse Epstein Barr Virus Induced 3 |
|||
| 7-00262 | CHI Scientific | 2µg | Ask for price |
Recombinant Mouse Epstein Barr Virus Induced 3 |
|||
| 7-00263 | CHI Scientific | 10µg | Ask for price |
Recombinant Mouse Epstein Barr Virus Induced 3 |
|||
| 7-00264 | CHI Scientific | 1mg | Ask for price |
Epstein-Barr virus EBNA-1 Recombinant Protein |
|||
| 53-311 | ProSci | 0.01 mg | EUR 915.9 |
|
Description: Epstein-Barr virus EBNA-1 Recombinant Protein |
|||
Recombinant Epstein-Barr Virus (HHV-4) p18 |
|||
| 7-07795 | CHI Scientific | 100µg | Ask for price |
Recombinant Epstein-Barr Virus (HHV-4) p18 |
|||
| 7-07796 | CHI Scientific | 500µg | Ask for price |
Recombinant Epstein-Barr Virus (HHV-4) p18 |
|||
| 7-07797 | CHI Scientific | 1000µg | Ask for price |
Recombinant Epstein-Barr Virus (HHV-4) p23 |
|||
| 7-07804 | CHI Scientific | 100µg | Ask for price |
Recombinant Epstein-Barr Virus (HHV-4) p23 |
|||
| 7-07805 | CHI Scientific | 500µg | Ask for price |
Recombinant Epstein-Barr Virus (HHV-4) p23 |
|||
| 7-07806 | CHI Scientific | 1000µg | Ask for price |
Human Epstein-Barr Virus (EBV) ELISA Kit |
|||
| abx054176-96tests | Abbexa | 96 tests | EUR 801.6 |
Epstein-Barr Virus Induced 3 (EBI3) Antibody |
|||
| abx232615-100ug | Abbexa | 100 ug | EUR 661.2 |
Epstein-Barr Virus (HHV-4) p18 Protein |
|||
| 20-abx260115 | Abbexa |
|
|
Epstein-Barr Virus (HHV-4) p23 Protein |
|||
| 20-abx260116 | Abbexa |
|
|
Epstein-Barr Virus (HHV-4) EBNA1 Protein |
|||
| 20-abx260340 | Abbexa |
|
|
Epstein-Barr Virus (HHV-4) p18 Protein |
|||
| 20-abx260341 | Abbexa |
|
|
Epstein-Barr Virus Induced 3 (EBI3) Antibody |
|||
| abx432634-200ul | Abbexa | 200 ul | EUR 343.2 |
Epstein-Barr virus EBNA-1 recombinant antigen |
|||
| 8916 | Virostat | 100 ug | EUR 738.6 |
|
Description: This is Epstein-Barr virus EBNA-1 recombinant antigen for ELISA,WB. |
|||
AAV1-GFP Control Virus |
|||
| AAV-301 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: GFP control virus of AAV serotype 1. |
|||
AAV2-GFP Control Virus |
|||
| AAV-302 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: GFP control virus of AAV serotype 2. |
|||
AAV3-GFP Control Virus |
|||
| AAV-303 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: GFP control virus of AAV serotype 3. |
|||
AAV4-GFP Control Virus |
|||
| AAV-304 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: GFP control virus of AAV serotype 4. |
|||
AAV5-GFP Control Virus |
|||
| AAV-305 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: GFP control virus of AAV serotype 5. |
|||
AAV6-GFP Control Virus |
|||
| AAV-306 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: GFP control virus of AAV serotype 6. |
|||
AAV2-Cre Control Virus |
|||
| AAV-310 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Cre control virus of AAV serotype 2. |
|||
AAV1-Cre Control Virus |
|||
| AAV-311 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Cre control virus of AAV serotype 1. |
|||
AAV3-Cre Control Virus |
|||
| AAV-313 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Cre control virus of AAV serotype 3. |
|||
AAV4-Cre Control Virus |
|||
| AAV-314 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Cre control virus of AAV serotype 4. |
|||
AAV5-Cre Control Virus |
|||
| AAV-315 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Cre control virus of AAV serotype 5. |
|||
AAV6-Cre Control Virus |
|||
| AAV-316 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Cre control virus of AAV serotype 6. |
|||
AAV2-Luc Control Virus |
|||
| AAV-320 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Luciferase control virus of AAV serotype 2. |
|||
AAV1-Luc Control Virus |
|||
| AAV-321 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Luciferase control virus of AAV serotype 1. |
|||
AAV3-Luc Control Virus |
|||
| AAV-323 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Luciferase control virus of AAV serotype 3. |
|||
AAV4-Luc Control Virus |
|||
| AAV-324 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Luciferase control virus of AAV serotype 4. |
|||
AAV5-Luc Control Virus |
|||
| AAV-325 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Luciferase control virus of AAV serotype 5. |
|||
AAV6-Luc Control Virus |
|||
| AAV-326 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Luciferase control virus of AAV serotype 6. |
|||
scAAV1-GFP Control Virus |
|||
| AAV-331 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Self-complementary GFP control virus of AAV serotype 1. |
|||
scAAV2-GFP Control Virus |
|||
| AAV-332 | Cell Biolabs | 50 ?L | EUR 1221.6 |
|
Description: Self-complementary GFP control virus of AAV serotype 2. |
|||
Inhibition of superior glycation end merchandise by isoferulic acid and its free radical scavenging functionality: An in vitro and molecular docking study.
Non-enzymatic glycation and Oxidation of some vital natural macromolecules are paramount inside the pathogenesis of various sicknesses along with diabetes and atherosclerosis.
- Hyperglycemia performs a key perform inside the pathological technique of diabetic issues by progressive accumulation of superior glycation end merchandise (AGEs) in physique tissues. Formation of AGEs on account of protein glycation is adopted by an elevated free radical train that furthermore contributes in course of the bio-macromolecular hurt.
- The present study aimed to guage the free radical scavenging and antiglycation functionality of isoferulic acid (IFA). The free radical scavenging train of IFA was measured using DPPH, FRAP, and metal chelating assays. IFA confirmed environment friendly reducing vitality, free radical scavenging train and metal chelation train in focus dependent technique.
- The antiglycation train of IFA was studied using quite a few spectroscopic strategies. The obtained outcomes had been validated with free amino, sulfhydryl group, carbonyl content material materials and AGEs formation. Secondary structural alterations had been monitored using spherical dichroism, morphology of aggregates was analyzed using transmission electron microscopy.
- Molecular docking reveals the doable binding location of IFA with inside the sub-domain IIA of human serum albumin (HSA).
LC/QTOF/MS/MS characterization, molecular docking and in silico toxicity prediction analysis on degradation products of anagliptin.
Pharmaceutical medicine are potential molecules with explicit natural train. Nonetheless, long-term use of these chemical molecules can impact the human physiological system because of their elevated ranges inside the human physique. Resulting from this truth, identification and development elucidation of impurities or degradation merchandise must be thought of in order to ensure drug safety.
The present study assessed the degradation behaviour of dipeptidyl peptidase-4 (DPP-4) inhibitor anagliptin under completely completely different stress conditions as per ICH suggestions Q1A (R2) adopted by elucidation of the development of degradation merchandise. All the stress samples had been analysed by using UPLC/PDA.
The superior separation of drug from its degradation merchandise was attained with time programmed gradient elution on BEH C18 (100 mm × 2.1 mm, 1.7 μm) column using 10 mM ammonium formate (aqueous) and acetonitrile (pure) as a result of the cell half components.
All the degradation merchandise of anagliptin had been characterised using LC/QTOF/MS/MS. In addition to, the train and toxicity of degradation merchandise had been determined by the use of molecular docking and in silico toxicity prediction analysis, respectively. The developed UPLC/PDA approach was validated as per ICH suggestions on the subject of specificity, accuracy, precision, linearity and robustnes
Molecular Distributions of Soluble Oxidation Merchandise from Coals Characterised by Mass Spectrometers.
Oxidation of three coals with rank from lignite to anthracite in NaOCl aqueous reply was investigated on this study. The oxidation merchandise had been characterised by using gasoline chromatography/mass spectrometry and direct analysis in real-time mass spectrometry.
The outcomes confirmed that almost all of pure compounds in coals had been reworked into water-soluble species under delicate conditions, even the anthracite. Benzene polycarboxylic acids (BPCAs) and chloro-substituted alkanoic acids (CSAAs) had been most important merchandise from the reactions.
The merchandise from lower rank coals embody considerable CSAAs and most merchandise from extreme rank coals are BPCAs. As coal rank will enhance, the yield of BPCAs with additional carboxylic groups will enhance.
Alpha-bungarotoxin CF488a |
|||
| 9-00005 | Biotium |
|
|
|
Description: Minimum order quantity: 1 unit of 100uG |
|||
Alpha-bungarotoxin, CF568 |
|||
| 9-00006 | Biotium |
|
|
|
Description: Minimum order quantity: 1 unit of 500uG |
|||
Alpha-bungarotoxin, CF568 |
|||
| 9-00006 | Biotium |
|
|
|
Description: Minimum order quantity: 1 unit of 100uG |
|||
Alpha-bungarotoxin, CF594 |
|||
| 9-00007 | Biotium |
|
|
|
Description: Minimum order quantity: 1 unit of 500uG |
|||
Alpha-bungarotoxin CF594 |
|||
| 9-00007 | Biotium |
|
|
|
Description: Minimum order quantity: 1 unit of 100uG |
|||
Alpha-bungarotoxin, CF633 |
|||
| 9-00009 | Biotium |
|
|
|
Description: Minimum order quantity: 1 unit of 500uG |
|||
Alpha-bungarotoxin, CF633 |
|||
| 9-00009 | Biotium |
|
|
|
Description: Minimum order quantity: 1 unit of 100uG |
|||
Alpha-bungarotoxin |
|||
| 00010-1 | Biotium | 1MG | EUR 201.6 |
|
Description: Minimum order quantity: 1 unit of 1MG |
|||
Fluorescein-Alpha-bungarotoxin |
|||
| 00011 | Biotium | 500uG | EUR 440.4 |
|
Description: Minimum order quantity: 1 unit of 500uG |
|||
Tetramethylrhodamine-Alpha-bungarotoxin |
|||
| 00012 | Biotium | 500uG | EUR 459.6 |
|
Description: Minimum order quantity: 1 unit of 500uG |
|||
Fluorescein-alpha-bungarotoxin: (10x50ug) |
|||
| 00013 | Biotium | 10ST | EUR 500.4 |
|
Description: Minimum order quantity: 1 unit of 10ST |
|||
Tetramethylrhodamine-alpha-bungarotoxin: (10x50ug) |
|||
| 00014 | Biotium | 10ST | EUR 559.2 |
|
Description: Minimum order quantity: 1 unit of 10ST |
|||
Sulforhodamine 101-a-bungarotoxin (Texas Red--a-bungarotoxin): (500ug) |
|||
| 00015 | Biotium | 500uG | EUR 559.2 |
|
Description: Minimum order quantity: 1 unit of 500uG |
|||
Sulforhodamine 101-a-bungarotoxin (Texas Red--a-bungarotoxin): (10x50ug) |
|||
| 00016 | Biotium | 10ST | EUR 627.6 |
|
Description: Minimum order quantity: 1 unit of 10ST |
|||
Biotin-xx-a-bungarotoxin |
|||
| 00017 | Biotium | 500uG | EUR 519.6 |
|
Description: Minimum order quantity: 1 unit of 500uG |
|||
Alpha-Bungarotoxin, CF555 conjugate |
|||
| 9-00018 | Biotium |
|
|
|
Description: Minimum order quantity: 1 unit of 500uG |
|||
Alpha-Bungarotoxin, CF555 conjugate |
|||
| 9-00018 | Biotium |
|
|
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
Biotin-cAMP, diisopropylethylammonium salt: |
|||
| 00020 | Biotium | 1MG | EUR 376.8 |
|
Description: Minimum order quantity: 1 unit of 1MG |
|||
Biotin-cAMP, diisopropylethylammonium salt: (20x50ug) |
|||
| 00020-1 | Biotium | 20ST | EUR 501.6 |
|
Description: Minimum order quantity: 1 unit of 20ST |
|||
Biotin-cGMP, diisopropylethylammonium salt: |
|||
| 00021 | Biotium | 1MG | EUR 412.8 |
|
Description: Minimum order quantity: 1 unit of 1MG |
|||
Biotin-cGMP, diisopropylethylammonium salt: (20x50ug) |
|||
| 00021-1 | Biotium | 20ST | EUR 537.6 |
|
Description: Minimum order quantity: 1 unit of 20ST |
|||
Cyanine 644-cAMP: |
|||
| 00022 | Biotium | 1MG | EUR 589.2 |
|
Description: Minimum order quantity: 1 unit of 1MG |
|||
Cyanine 644-cAMP: (20x50ug) |
|||
| 00022-1 | Biotium | 20ST | EUR 750 |
|
Description: Minimum order quantity: 1 unit of 20ST |
|||
Fluorescein Methotrexate, triammonium salt: |
|||
| 00023 | Biotium | 1MG | EUR 337.2 |
|
Description: Minimum order quantity: 1 unit of 1MG |
|||
Staurosporine |
|||
| 00025 | Biotium | 100uG | EUR 166.8 |
|
Description: Minimum order quantity: 1 unit of 100uG |
|||
Alpha-bungarotoxin, CF543 |
|||
| 00026 | Biotium | 500uG | EUR 592.8 |
|
Description: Minimum order quantity: 1 unit of 500uG |
|||
Rhodamine phalloidin 300u |
|||
| 00027 | Biotium | 300 | EUR 414 |
|
Description: Minimum order quantity: 1 unit of 300 |
|||
Biotin-xx-phalloidin |
|||
| 00028 | Biotium | 100U | EUR 513.6 |
|
Description: Minimum order quantity: 1 unit of 100U |
|||
Fluorescein-phalloidin |
|||
| 00030 | Biotium | 300U | EUR 414 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Rhodamine 110 phalloidin |
|||
| 00032 | Biotium | 300ST | EUR 414 |
|
Description: Minimum order quantity: 1 unit of 300ST |
|||
Sulforhodamine 101 (Texas-Red) Phalloidin |
|||
| 00033 | Biotium | 300EU | EUR 414 |
|
Description: Minimum order quantity: 1 unit of 300EU |
|||
Phalloidin, CF405M |
|||
| 00034 | Biotium | 300U | EUR 530.4 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF405M |
|||
| 00034-T | Biotium | 50U | EUR 159.6 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
CF488A-cAMP |
|||
| 00036 | Biotium | 100ug | EUR 206.4 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
CF640R-cAMP |
|||
| 00037 | Biotium | 100ug | EUR 206.4 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
Phalloidin, CF555 |
|||
| 00040 | Biotium | 300U | EUR 530.4 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF555 |
|||
| 00040-T | Biotium | 50U | EUR 159.6 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF647 |
|||
| 00041 | Biotium | 300U | EUR 530.4 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF647 |
|||
| 00041-T | Biotium | 50U | EUR 159.6 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF488A |
|||
| 00042 | Biotium | 300U | EUR 530.4 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF488A |
|||
| 00042-T | Biotium | 50U | EUR 159.6 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF543 |
|||
| 00043 | Biotium | 300U | EUR 530.4 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF543 |
|||
| 00043-T | Biotium | 50U | EUR 159.6 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF568 |
|||
| 00044 | Biotium | 300U | EUR 530.4 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF568 |
|||
| 00044-T | Biotium | 50U | EUR 159.6 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF594 |
|||
| 00045 | Biotium | 300U | EUR 530.4 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF594 |
|||
| 00045-T | Biotium | 50U | EUR 159.6 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF633 |
|||
| 00046 | Biotium | 300U | EUR 530.4 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF633 |
|||
| 00046-T | Biotium | 50U | EUR 159.6 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF660R |
|||
| 00047 | Biotium | 300U | EUR 530.4 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF660R |
|||
| 00047-T | Biotium | 50U | EUR 159.6 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF680R |
|||
| 00048 | Biotium | 300U | EUR 559.2 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF680R |
|||
| 00048-T | Biotium | 50U | EUR 159.6 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF350 |
|||
| 00049 | Biotium | 300U | EUR 530.4 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF350 |
|||
| 00049-T | Biotium | 50U | EUR 159.6 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF640R |
|||
| 00050 | Biotium | 300U | EUR 530.4 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF640R |
|||
| 00050-T | Biotium | 50U | EUR 159.6 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF532 |
|||
| 00051 | Biotium | 300U | EUR 530.4 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF532 |
|||
| 00051-T | Biotium | 50U | EUR 159.6 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF660C |
|||
| 00052 | Biotium | 300U | EUR 530.4 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF660C |
|||
| 00052-T | Biotium | 50U | EUR 159.6 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF680 |
|||
| 00053 | Biotium | 300U | EUR 559.2 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF680 |
|||
| 00053-T | Biotium | 50U | EUR 176.4 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF430 |
|||
| 00054 | Biotium | 300U | EUR 538.8 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF430 |
|||
| 00054-T | Biotium | 50U | EUR 166.8 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Phalloidin, CF440 |
|||
| 00055 | Biotium | 300U | EUR 538.8 |
|
Description: Minimum order quantity: 1 unit of 300U |
|||
Phalloidin, CF440 |
|||
| 00055-T | Biotium | 50U | EUR 166.8 |
|
Description: Minimum order quantity: 1 unit of 50U |
|||
Cholera Toxin Subunit B, CF488A conjugate |
|||
| 00070 | Biotium | 100ug | EUR 313.2 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
Cholera Toxin Subunit B, CF568 conjugate |
|||
| 00071 | Biotium | 100ug | EUR 313.2 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
Cholera Toxin Subunit B, CF594 conjugate |
|||
| 00072 | Biotium | 100ug | EUR 313.2 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
Cholera Toxin Subunit B, CF640R conjugate |
|||
| 00073 | Biotium | 100ug | EUR 316.8 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
Cholera Toxin Subunit B, CF532 conjugate |
|||
| 00074 | Biotium | 100ug | EUR 316.8 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
Cholera Toxin Subunit B, CF543 conjugate |
|||
| 00075 | Biotium | 100ug | EUR 316.8 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
Cholera Toxin Subunit B, CF620R conjugate |
|||
| 00076 | Biotium | 100ug | EUR 316.8 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
Cholera Toxin Subunit B, CF633 conjugate |
|||
| 00077 | Biotium | 100ug | EUR 316.8 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
Cholera Toxin Subunit B, CF660R conjugate |
|||
| 00078 | Biotium | 100ug | EUR 316.8 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
Cholera Toxin Subunit B, CF680R conjugate |
|||
| 00079 | Biotium | 100ug | EUR 338.4 |
|
Description: Minimum order quantity: 1 unit of 100ug |
|||
Human Transferrin, CF488A conjugate |
|||
| 00081 | Biotium | 1mg | EUR 178.8 |
|
Description: Minimum order quantity: 1 unit of 1mg |
|||
Human Transferrin, CF543 conjugate |
|||
| 00082 | Biotium | 1mg | EUR 178.8 |
|
Description: Minimum order quantity: 1 unit of 1mg |
|||
Human Transferrin, CF568 conjugate |
|||
| 00083 | Biotium | 1mg | EUR 178.8 |
|
Description: Minimum order quantity: 1 unit of 1mg |
|||
Human Transferrin, CF594 conjugate |
|||
| 00084 | Biotium | 1mg | EUR 178.8 |
|
Description: Minimum order quantity: 1 unit of 1mg |
|||
Human Transferrin, CF640R conjugate |
|||
| 00085 | Biotium | 1mg | EUR 178.8 |
|
Description: Minimum order quantity: 1 unit of 1mg |
|||
Human Transferrin, CF680R conjugate |
|||
| 00086 | Biotium | 1mg | EUR 178.8 |
|
Description: Minimum order quantity: 1 unit of 1mg |
|||
Human Transferrin, CF750 conjugate |
|||
| 00087 | Biotium | 1mg | EUR 186 |
|
Description: Minimum order quantity: 1 unit of 1mg |
|||
HIV-1 tat recombinant antigen |
|||
| 00110-V-01mg | Virogen | 0,1 mg | EUR 321 |
|
Description: HIV-1 tat recombinant antigen full length 15 kDa |
|||
HIV-1 tat recombinant antigen |
|||
| 00110-V-1000ug | Virogen | 1000 ug | EUR 1539 |
|
Description: HIV-1 tat recombinant antigen full length 15 kDa |
|||
HIV-1 GAG P24 Recombinant Antigen |
|||
| 00111-V-01mg | Virogen | 0,1 mg | EUR 321 |
|
Description: HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa |
|||
HIV-1 GAG P24 Recombinant Antigen |
|||
| 00111-V-1000ug | Virogen | 1000 ug | EUR 1539 |
|
Description: HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa |
|||
HIV-1 nef recombinant antigen |
|||
| 00112-V-01mg | Virogen | 0,1 mg | EUR 321 |
|
Description: HIV-1 nef recombinant antigen a.a 3 to a.a 190 of the HIV-1 nef region 20 kDa |
|||
HIV-1 nef recombinant antigen |
|||
| 00112-V-1000ug | Virogen | 1000 ug | EUR 1539 |
|
Description: HIV-1 nef recombinant antigen a.a 3 to a.a 190 of the HIV-1 nef region 20 kDa |
|||
HIV-1 env gp41 recombinant antigen |
|||
| 00113-V-01mg | Virogen | 0,1 mg | EUR 321 |
|
Description: HIV-1 env gp41 recombinant antigen a.a 466 to a.a 753 of the HIV-1 env region 32 kDa |
|||
HIV-1 env gp41 recombinant antigen |
|||
| 00113-V-1000ug | Virogen | 1000 ug | EUR 1539 |
|
Description: HIV-1 env gp41 recombinant antigen a.a 466 to a.a 753 of the HIV-1 env region 32 kDa |
|||
HIV-2 GP 36 Recombinant Antigen |
|||
| 00114-V-01mg | Virogen | 0,1 mg | EUR 321 |
|
Description: HIV -2 env gp36 recombinant antigen a.a 390 to a.a 702 of the HIV-2 env region 34 kDa |
|||
HIV-2 GP 36 Recombinant Antigen |
|||
| 00114-V-1000ug | Virogen | 1000 ug | EUR 1539 |
|
Description: HIV -2 env gp36 recombinant antigen a.a 390 to a.a 702 of the HIV-2 env region 34 kDa |
|||
HCV core recombinant antigen |
|||
| 00115-V-01mg | Virogen | 0,1 mg | EUR 321 |
|
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa |
|||
HCV core recombinant antigen |
|||
| 00115-V-1000ug | Virogen | 1000 ug | EUR 1539 |
|
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa |
|||
HCV core recombinant antigen, Biotin conjugate |
|||
| 00115-V-B-01mg | Virogen | 0,1 mg | EUR 321 |
|
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa. Biotin conjugate. |
|||
HCV core recombinant antigen, Biotin conjugate |
|||
| 00115-V-B-1000ug | Virogen | 1000 ug | EUR 1539 |
|
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa. Biotin conjugate. |
|||